Anika Therapeutics reported $43.04M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agenus AGEN:US $ 65.49M 4.09M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
Chemocentryx CCXI:US $ 43.34M 355K
Clovis Oncology CLVS:US $ 91.52M 6.92M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Immunogen IMGN:US $ 75.22M 14.28M
Insmed INSM:US $ 153.54M 10.6M
Integra Lifesciences IART:US $ 336.76M 7.57M
Intrexon XON:US $ 27.07M 22.84M
Johnson & Johnson JNJ:US $ 18.18B 616M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Macrogenics MGNX:US $ 67.82M 9.92M
Merit Medical Systems MMSI:US $ 271.72M 11.54M
Peregrine Pharmaceuticals PPHM:US $ 30.16M 1.92M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Stryker SYK:US $ 3.72B 107M
Surmodics SRDX:US $ 32M 991K
Veracyte VCYT:US $ 83.6M 566K
Xencor XNCR:US $ 58.18M 854K
Zimmer Biomet Holdings Inc ZBH:US $ 1.5B 36.1M